Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - TAKEDA PHARMACEUTICAL CO LTD

7th Jun 2018 13:24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 06 June 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 14,239,026 1.79% 15,710,731 1.98%
(2) Cash-settled derivatives:
14,866,490 1.87% 13,676,200 1.72%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 13,623,700 1.71% 14,043,700 1.77%
TOTAL: 42,729,216 5.38% 43,430,631 5.47%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 100 4,300.5000 JPY
ORD Purchase 200 4,301.0000 JPY
ORD Purchase 300 4,300.8333 JPY
ORD Purchase 1,000 4,300.8000 JPY
ORD Purchase 1,200 4,286.6667 JPY
ORD Purchase 1,500 4,295.4666 JPY
ORD Purchase 1,500 4,284.8666 JPY
ORD Purchase 9,100 4,296.0879 JPY
ORD Purchase 9,500 4,302.0452 JPY
ORD Purchase 12,700 4,279.5905 JPY
ORD Purchase 20,700 4,304.0000 JPY
ORD Purchase 22,500 4,283.0000 JPY
ORD Purchase 41,000 4,289.5292 JPY
ORD Purchase 132,600 4,286.2654 JPY
ADR Purchase 151,100 19.5356 USD
ORD Purchase 211,100 4,289.6357 JPY
ORD Sale 500 4,300.9000 JPY
ORD Sale 1,000 4,304.0000 JPY
ORD Sale 1,000 4,300.8000 JPY
ORD Sale 2,400 4,265.8750 JPY
ORD Sale 9,100 4,296.0879 JPY
ORD Sale 9,600 4,302.0291 JPY
ORD Sale 13,500 4,281.0370 JPY
ORD Sale 15,400 4,302.3961 JPY
ORD Sale 132,600 4,286.0015 JPY
ADR Sale 151,100 19.5356 USD
ORD Sale 213,000 4,286.2079 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Short 19,700 4,304.0000 JPY
ORD SWAP Short 19,700 4,304.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 7 Jun 2018
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
ORD Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
ORD Call Options Purchased 48,000 4625.0000 European 12 Oct 2018
ORD Put Options Written 13,200,000 4260.0000 European 6 Jul 2018
ORD Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
ORD Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
ORD Call Options Written -78,000 5781.0000 European 14 Dec 2018
ORD Put Options Purchased -13,200,000 4260.0000 European 6 Jul 2018
ORD Call Options Written -13,200,000 4260.0000 European 6 Jul 2018
ORD Call Options Written -460,000 6182.0000 European 14 Dec 2018
ORD Call Options Written -104,700 5065.8300 European 17 Apr 2019
ORD Put Options Written 104,700 5065.8300 European 17 Apr 2019
ORD Put Options Purchased -48,000 4625.0000 European 12 Oct 2018
ORD Put Options Written 78,000 5781.0000 European 14 Dec 2018
ORD Put Options Written 114,000 4750.0200 European 14 May 2019
ORD Call Options Purchased 13,200,000 4260.0000 European 6 Jul 2018
ORD Call Options Written -114,000 4750.0200 European 14 May 2019
ORD Call Options Purchased 20,700 175.0000 American 20 Jul 2018
ORD Put Options Written 2,100 140.0000 American 20 Jul 2018
ORD Call Options Purchased 1,700 195.0000 American 17 Jan 2020
ORD Call Options Purchased 1,000 180.0000 American 17 Jan 2020
ORD Call Options Purchased 1,000 170.0000 American 17 Jan 2020
ORD Call Options Purchased 200 135.0000 American 17 Jan 2020
ORD Call Options Purchased 100 175.0000 American 18 Jan 2019
ORD Put Options Written 100 110.0000 American 17 Jan 2020
ORD Put Options Purchased -1,500 165.0000 American 18 Jan 2019
ORD Put Options Purchased -2,700 80.0000 American 18 Jan 2019
ORD Put Options Purchased -5,800 180.0000 American 18 Jan 2019
ORD Put Options Purchased -7,700 130.0000 American 18 Jan 2019
ORD Put Options Purchased -22,500 170.0000 American 15 Jun 2018
ORD Put Options Purchased -44,000 145.0000 American 19 Oct 2018
ORD Put Options Purchased -400 165.0000 American 17 Jan 2020
ORD Put Options Purchased -700 160.0000 American 17 Jan 2020
ORD Put Options Purchased -1,000 150.0000 American 18 Jan 2019
ORD Call Options Purchased 1,600 170.0000 American 19 Oct 2018
ORD Call Options Written -100 125.0000 American 20 Jul 2018
ORD Put Options Written 22,700 155.0000 American 20 Jul 2018
ORD Call Options Purchased 13,500 170.0000 American 15 Jun 2018
ORD Call Options Purchased 3,600 185.0000 American 19 Oct 2018
ORD Call Options Purchased 3,100 155.0000 American 18 Jan 2019
ORD Put Options Written 2,900 95.0000 American 20 Jul 2018
ORD Put Options Written 1,000 90.0000 American 18 Jan 2019
ORD Call Options Purchased 600 125.0000 American 18 Jan 2019
ORD Call Options Purchased 400 230.0000 American 18 Jan 2019
ORD Call Options Purchased 300 115.0000 American 18 Jan 2019
ORD Put Options Written 200 200.0000 American 17 Jan 2020
ORD Put Options Written 200 125.0000 American 19 Oct 2018
ORD Put Options Written 200 135.0000 American 20 Jul 2018
ORD Call Options Purchased 100 220.0000 American 18 Jan 2019
ORD Call Options Purchased 100 165.0000 American 15 Jun 2018
ORD Put Options Written 100 95.0000 American 18 Jan 2019
ORD Call Options Written -1,600 145.0000 American 18 Jan 2019
ORD Put Options Purchased -2,200 110.0000 American 20 Jul 2018
ORD Put Options Purchased -2,500 120.0000 American 17 Jan 2020
ORD Put Options Purchased -100 120.0000 American 20 Jul 2018
ORD Call Options Written -100 140.0000 American 17 Jan 2020
ORD Call Options Written -400 173.0000 American 22 Jun 2018
ORD Call Options Written -900 145.0000 American 20 Jul 2018
ORD Call Options Written -1,000 85.0000 American 18 Jan 2019
ORD Call Options Purchased 4,500 200.0000 American 18 Jan 2019
ORD Call Options Purchased 5,800 165.0000 American 20 Jul 2018
ORD Call Options Purchased 200 155.0000 American 17 Jan 2020
ORD Call Options Purchased 200 130.0000 American 17 Jan 2020
ORD Call Options Written -1,500 148.0000 American 22 Jun 2018
ORD Call Options Written -100 163.0000 American 15 Jun 2018
ORD Put Options Purchased -200 170.0000 American 18 Jan 2019
ORD Call Options Written -400 115.0000 American 20 Jul 2018
ORD Call Options Written -600 175.0000 American 19 Oct 2018
ORD Put Options Purchased -800 150.0000 American 17 Jan 2020
ORD Call Options Purchased 12,500 163.0000 American 15 Jun 2018
ORD Call Options Purchased 2,200 185.0000 American 18 Jan 2019
ORD Call Options Purchased 500 165.0000 American 18 Jan 2019
ORD Put Options Written 500 125.0000 American 20 Jul 2018
ORD Call Options Purchased 300 195.0000 American 18 Jan 2019
ORD Call Options Purchased 200 120.0000 American 17 Jan 2020
ORD Call Options Purchased 100 173.0000 American 15 Jun 2018
ORD Put Options Purchased -1,200 115.0000 American 20 Jul 2018
ORD Call Options Written -8,000 180.0000 American 18 Jan 2019
ORD Call Options Written -162,000 165.0000 American 15 Jun 2018
ORD Put Options Purchased -200 115.0000 American 19 Oct 2018
ORD Put Options Purchased -1,000 105.0000 American 18 Jan 2019
ORD Call Options Purchased 1,500 140.0000 American 20 Jul 2018
ORD Call Options Purchased 1,100 170.0000 American 18 Jan 2019
ORD Call Options Purchased 200 160.0000 American 17 Jan 2020
ORD Put Options Purchased -2,300 85.0000 American 18 Jan 2019
ORD Call Options Written -4,300 170.0000 American 20 Jul 2018
ORD Put Options Purchased -6,000 135.0000 American 18 Jan 2019
ORD Put Options Purchased -7,500 155.0000 American 18 Jan 2019
ORD Put Options Purchased -100 150.0000 American 20 Jul 2018
ORD Call Options Written -100 130.0000 American 18 Jan 2019
ORD Call Options Written -300 150.0000 American 20 Jul 2018
ORD Put Options Purchased -500 140.0000 American 17 Jan 2020
ORD Put Options Purchased -1,000 80.0000 American 17 Jan 2020
ORD Call Options Purchased 37,200 160.0000 American 15 Jun 2018
ORD Call Options Purchased 4,200 180.0000 American 20 Jul 2018
ORD Put Options Written 2,800 120.0000 American 18 Jan 2019
ORD Call Options Purchased 1,000 160.0000 American 20 Jul 2018
ORD Call Options Purchased 500 165.0000 American 22 Jun 2018
ORD Call Options Purchased 100 110.0000 American 17 Jan 2020
ORD Call Options Purchased 100 140.0000 American 18 Jan 2019
ORD Put Options Written 100 140.0000 American 19 Oct 2018
ORD Put Options Purchased -2,000 175.0000 American 19 Oct 2018
ORD Put Options Purchased -2,100 160.0000 American 18 Jan 2019
ORD Put Options Purchased -3,700 145.0000 American 17 Jan 2020
ORD Put Options Purchased -1,100 140.0000 American 18 Jan 2019
ORD Call Options Purchased 4,100 135.0000 American 20 Jul 2018
ORD Put Options Written 4,100 150.0000 American 15 Jun 2018
ORD Call Options Purchased 2,000 150.0000 American 17 Jan 2020
ORD Call Options Purchased 1,000 135.0000 American 18 Jan 2019
ORD Put Options Written 700 85.0000 American 20 Jul 2018
ORD Call Options Purchased 500 150.0000 American 18 Jan 2019
ORD Call Options Purchased 400 185.0000 American 20 Jul 2018
ORD Put Options Written 200 70.0000 American 19 Oct 2018
ORD Put Options Written 200 145.0000 American 20 Jul 2018
ORD Put Options Written 100 110.0000 American 18 Jan 2019
ORD Put Options Written 100 75.0000 American 19 Oct 2018
ORD Put Options Purchased -1,800 115.0000 American 18 Jan 2019
ORD Put Options Purchased -2,400 75.0000 American 20 Jul 2018
ORD Call Options Written -2,600 175.0000 American 15 Jun 2018
ORD Put Options Purchased -500 145.0000 American 18 Jan 2019
ORD Put Options Purchased -1,000 170.0000 American 17 Jan 2020
ORD Put Options Purchased -1,200 135.0000 American 17 Jan 2020

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180607005579/en/

Copyright Business Wire 2018


Related Shares:

Barclays
FTSE 100 Latest
Value8,785.34
Change49.74